Effect of Remote Ischemic Conditioning on Ischemia and Reperfusion Injury in Patients Submitted to Coronary Artery Bypass Grafting.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Coronary Artery Bypass
- Sponsor
- Medinet Heart Centre
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Postoperative myocardial necrosis
- Last Updated
- 8 years ago
Overview
Brief Summary
This study evaluates the addition of remote ischemic preconditioning and postconditioning to standard myocardial protection protocol in patients submitted to off - pump coronary artery bypass grafting in a prospective, 1:1 randomized, double blind fashion. An interventional group will receive remote ischemic preconditioning 24-hours before OP-CABG, immediately before surgery and within 60 minutes following surgery by means of lower limb ischemia achieved by pressure cuff inflation, whereas control group will receive sham procedure perioperatively.
Detailed Description
In a prospective, 1:1 randomized and double blind fashion, the study will evaluate the impact of remote ischemic preconditioning, both immediate and second window of protection (24 hours and immediately before surgery) with remote ischemic postconditiong on operative outcomes in patients submitted to coronary artery bypass grafting without use of extracorporeal circulation. Remote ischemic conditioning was found to provide protection against necrosis and apoptosis due to ischemia and reperfusion injury, a phenomenon observed during coronary artery bypass grafting. That in turn was associated with poor postoperative outcomes, predominantly poor survival. Remote ischemic preconditioning will be provided by repeated lower leg ischemia and reperfusion with pressure cuff inflation for five minutes and deflation for five minutes in three consecutive cycles. Remote ischemic preconditioning will be performed 24 hours before CABG and immediately before surgery. Remote ischemic postconditioning will be performed within 60 minutes following the last coronary artery bypass graft completion and the restoration of coronary blood flow. The study will assess clinical endpoints such as postoperative acute myocardial infarction (type 5 MI), postoperative mortality, postoperative renal failure and laboratory outcomes such as postoperative serial measurements of troponin T release or glomerular filtration rate as secondary outcomes.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients qualified to coronary artery bypass grafting according to ESC/EACTS Guidelines of myocardial revascularization, suffering from:
- •Multivessel coronary artery disease amenable for surgical treatment
- •Negative history of previous cardiac or vascular surgery in childhood and afterwards.
- •Negative history of active neoplastic disease, neither past medical history of oncological treatment
- •Patients with non insulin dependent diabetes mellitus treated chronically with oral derivatives of sulfonylourea such as but not limited to: glibenclamide.
Exclusion Criteria
- •Patients suffering from acute insuficiency of any organ/ system and those suffering from end stage organ failure such as:
- •Chronic renal disease - KDOQI stage ≥ 3;
- •Chronic renal failure class A by Child - Pugh'a;
- •Chronic respiratory failure (type I and II according to Campbell et al. and type I according to Wood et al.);
- •Chronic intermittent claudication class 2A according to Fontaine;
Outcomes
Primary Outcomes
Postoperative myocardial necrosis
Time Frame: 72 hours postoperatively
Serial mesurements of High - Sensitive Troponin T release
Postoperative kidney injury
Time Frame: 7 days postoperatively
Serial measurements of estimated glomerular filtration rate by creatinine
Secondary Outcomes
- Postoperative Acute Kidney Injury(30 days)
- Perioperative mortality(30 days postoperatively)
- Perioperative myocardial infarction(30 days postoperatively)